Selected publications
- Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomised controlled trials. European Journal of Cancer. 2019 Academic Article GET IT
- Assessment of Treatment with Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients with Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial. JAMA oncology. 2019 Academic Article GET IT
-
A study of thymidylate synthase expression as a biomarker for resectable colon cancer: Alliance (cancer and Leukemia group B) 9581 and 89803.
Oncologist.
2017
Academic Article
GET IT
Times cited: 2 -
Coffee intake, recurrence, and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).
Journal of Clinical Oncology.
2015
Academic Article
GET IT
Times cited: 24 -
Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
Journal of the National Cancer Institute.
2015
Academic Article
GET IT
Times cited: 78 -
MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial.
PLoS ONE.
2014
Academic Article
GET IT
Times cited: 10 -
Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance).
PLoS ONE.
2014
Academic Article
GET IT
Times cited: 22 -
25-hydroxyvitamin D levels and survival in advanced pancreatic cancer: Findings from CALGB 80303 (Alliance).
Journal of the National Cancer Institute.
2014
Academic Article
GET IT
Times cited: 14 -
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer.
Gastroenterology.
2014
Academic Article
GET IT
Times cited: 71 -
Predictive and prognostic analysis of PIK3CA mutation in stage II colon cancer intergroup trial.
Journal of the National Cancer Institute.
2013
Academic Article
GET IT
Times cited: 36 -
Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/alliance.
Clinical Colorectal Cancer.
2013
Academic Article
GET IT
Times cited: 16 -
Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: Results of CALGB 89803.
Clinical Cancer Research.
2013
Academic Article
GET IT
Times cited: 19 -
Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data.
European Journal of Cancer.
2013
Review
GET IT
Times cited: 91 -
Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: Findings from CALGB 89803 and CALGB 80405.
Clinical Colorectal Cancer.
2013
Academic Article
GET IT
Times cited: 13 -
Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803.
Journal of the National Cancer Institute.
2012
Academic Article
GET IT
Times cited: 87 -
Relationship between statin use and colon cancer recurrence and survival: Results from CALGB 89803.
Journal of the National Cancer Institute.
2011
Academic Article
GET IT
Times cited: 50 -
Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: Results from CALGB 9581.
Journal of Clinical Oncology.
2011
Academic Article
GET IT
Times cited: 42 -
Microsatellite instability and loss of heterozygosity at chromosomal location 18q: Pospective evaluation of biomarkers for stages II and III colon cancer - A study of CALGB 9581 and 89803.
Journal of Clinical Oncology.
2011
Academic Article
GET IT
Times cited: 102 -
A Cancer and Leukemia group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).
Oncologist.
2010
Academic Article
GET IT
Times cited: 54 -
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: Findings from CALGB 89803.
Journal of Clinical Oncology.
2010
Academic Article
GET IT
Times cited: 25 -
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: Phase III trial of the Cancer and Leukemia Group B (CALGB 80303).
Journal of Clinical Oncology.
2010
Academic Article
GET IT
Times cited: 579 -
Impact of smoking on patients with stage iii colon cancer: Results from cancer and leukemia group B 89803.
Cancer.
2010
Academic Article
GET IT
Times cited: 42 -
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.
Clinical Cancer Research.
2009
Academic Article
GET IT
Times cited: 149 -
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and leukemia group B protocol 89803.
Journal of Clinical Oncology.
2009
Academic Article
GET IT
Times cited: 280 -
P27 Kip1 in stage III colon cancer: Implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.
Clinical Cancer Research.
2009
Academic Article
GET IT
Times cited: 14 -
Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: Findings from cancer and leukemia group B 89803.
Journal of Clinical Oncology.
2008
Academic Article
GET IT
Times cited: 154 -
Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
JAMA - Journal of the American Medical Association.
2008
Academic Article
GET IT
Times cited: 59 -
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
Obstetrical and Gynecological Survey.
2008
Comment
GET IT
Times cited: 1 -
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
JAMA - Journal of the American Medical Association.
2007
Academic Article
GET IT
Times cited: 258 -
Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: Results of CALGB 89803.
Journal of Clinical Oncology.
2007
Academic Article
GET IT
Times cited: 324 -
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803.
Journal of Clinical Oncology.
2006
Academic Article
GET IT
Times cited: 487 -
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
Journal of Clinical Oncology.
2006
Academic Article
GET IT
Times cited: 283 -
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and leukemia group B 509901.
Journal of immunotherapy (Hagerstown, Md. : 1997).
2006
Academic Article
GET IT
Times cited: 21 -
High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.
Leukemia and Lymphoma.
2001
Academic Article
GET IT
Times cited: 2 -
Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.
Journal of Clinical Oncology.
1993
Academic Article
GET IT
Times cited: 71 -
Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor.
Journal of the National Cancer Institute.
1993
Academic Article
GET IT
Times cited: 136 -
A pilot study of hepatic artery floxuridine combined with systemic 5‐fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
Cancer.
1993
Academic Article
GET IT
Times cited: 53 -
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors.
Cancer.
1993
Academic Article
GET IT
Times cited: 247 -
Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.
Journal of Clinical Oncology.
1992
Academic Article
GET IT
Times cited: 20 -
FAMTX versus etoposide, doxorubicin, and cisplatin: A random assignment trial in gastric cancer.
Journal of Clinical Oncology.
1992
Academic Article
GET IT
Times cited: 281 -
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
Cancer.
1992
Academic Article
GET IT
Times cited: 195 -
Histologic predictors of survival in acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
Human Pathology.
1992
Academic Article
GET IT
Times cited: 10 -
Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.
Cancer.
1992
Academic Article
GET IT
Times cited: 55 -
A new syndrome: Ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA).
Annals of Internal Medicine.
1991
Academic Article
GET IT
Times cited: 17 -
A phase III comparison trial of streptozotocin, mitomycin, and 5‐fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.
Cancer.
1991
Academic Article
GET IT
Times cited: 82 -
Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia.
Leukemia Research.
1991
Academic Article
GET IT
Times cited: 50 -
Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.
Journal of Clinical Oncology.
1990
Academic Article
GET IT
Times cited: 102 -
Toxoplasma gondii serology in HIV-infected patients: The development of central nervous system toxoplasmosis in AIDS.
AIDS.
1990
Academic Article
GET IT
Times cited: 166 -
Carboplatin-based chemotherapy with pharmacokinetic analysis for patients with hemodialysis-dependent renal insufficiency.
Cancer Chemotherapy and Pharmacology.
1990
Academic Article
GET IT
Times cited: 29 -
Advanced pancreatic cancer: A phase I-II trial of cisplatin, high-dose cytarabine, and caffeine.
Journal of the National Cancer Institute.
1989
Academic Article
GET IT
Times cited: 22 -
Intrahepatic mitomycin C as a salvage treatment for patients with hepatic metastases from colorectal carcinoma.
Cancer.
1989
Academic Article
GET IT
Times cited: 10 -
Randomized Trial of Combined Modality Therapy with and without Thymosin Fraction V in the Treatment of Small Cell Lung Cancer.
Cancer Research.
1988
Academic Article
GET IT
Times cited: 20 -
Pharmacokinetics of cis-Diamminedichloroplatinum(II) after Administration in Hypertonic Saline.
Cancer Research.
1986
Academic Article
GET IT
Times cited: 33 -
Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease.
Cancer Chemotherapy and Pharmacology.
1986
Academic Article
GET IT
Times cited: 15